Search Results 61-70 of 8350 for TNF

  1. Stacey A. Rizza, M.D. - Mayo Clinic Faculty Profiles

    Role of TNF-receptor apoptosis inducing ligand (TRAIL) and hepatocyte apoptosis during co-infection. Significance to patient care. Although there have been ...

  2. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Tumor necrosis factor-alpha (TNF-α) antagonists: • Signs and symptoms of persistently active disease despite a history of at least 1 induction regimen of ...

  3. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  4. Mayo Clinic research sheds light on why some rheumatoid arthritis patients respond poorly to biologics

    ... tumor necrosis factor inhibitors, part of a class of drugs called biologics. ... tumor necrosis factor inhibitors as others. They looked at white blood ...

  5. Health care maintenance in patients with IBD - Mayo Clinic

    For example, patients who are receiving combination therapy with anti-TNF agents and an immunosuppressive drug have a blunted response to the pneumococcal ...

  6. The effects of bed rest on cardiac and muscle-pump baroreflexes - Mayo Clinic

    ... tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), total tau protein (t-Tau), insulin-like growth factor 1 (IGF-1), brain-derived neurotrophic ...

  7. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    More information. Publications. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. ... tumor necrosis factor ( ...

  8. Juvenile idiopathic arthritis - Diagnosis and treatment - Mayo Clinic

    Also known as biologic response modifiers, this newer class of drugs includes tumor necrosis factor (TNF) blockers, such as etanercept (Enbrel, Erelzi ...

  9. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

    ... TNF-biologic. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  10. Arthritis Clinical Trials

    ... TNF alpha agents. Treatment of Thumb Carpometacarpal (CMC) Arthritis Using Stablyx® CMC Arthroplasty System Rochester, MN. The purpose of this study is to ...